Macrogenics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Macrogenics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $0.27 | $-0.39 | 169.2 % |
| Q2 | 2025-08-14 | $-0.57 | $-0.01 | -5600.0 % |
| Q1 | 2025-05-13 | $-0.65 | $-0.69 | 5.80 % |
| Q4 | 2025-03-20 | $-0.25 | $-0.59 | 57.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $72.84M | $28.56M | 155.1 % |
| Q2 | 2025-08-14 | $22.24M | $25.33M | -12.2 % |
| Q1 | 2025-05-13 | $13.19M | $9.59M | 37.6 % |
| Q4 | 2025-03-20 | $19.35M | $34.17M | -43.4 % |
Macrogenics (MGNX) is scheduled to report earnings on March 19, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
The Actual EPS was $0.27, which beat the estimate of $-0.39.
The Actual Revenue was $72.8M, which beat the estimate of $28.6M.
Browse earnings estimates, EPS, and revenue on all stocks.